skip to content

School of the Biological Sciences



Head of Target Discovery, Milner Therapeutics Institute 

Rebecca Harris leads the experimental research programme within the Centre for Pathway Analysis there, working on collaborative projects with Cambridge academics to develop clinically relevant, well validated targets for disease therapy. Rebecca also works closely with the CRUK Cambridge Centre to support the conversion of preclinical oncology research to clinical impact, through research, industry engagement and entrepreneurship. Learn more. 


Research Areas

Cell biology
Target validation
Drug discovery
Inflamamatory disease


Live cell imaging 
Complex cell assays
Hypoxic assays

Areas for Collaboration

Target identification
Target validation
Drug discovery
Complex cell assays
Tumour microenvironment


Research Theme